Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 16,675 |
|
|||||
| News | - | ||||||
| Day High | 0.3583 | Low High |
|||||
| Day Low | 0.3325 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Dermata Therapeutics Inc | DRMA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0026 | 0.76% | 0.3427 | 16:50:06 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.346 | 0.3325 | 0.3583 | 0.3427 | 0.3401 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 103 | 16,675 | US$ 0.3393863 | US$ 5,659 | - | 0.237372 - 2.8101 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:50:06 | 1 | US$ 0.355 | USD |
Dermata Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.08M | 3.19M | - | 0 | -7.8M | -2.44 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Dermata Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/12/2024 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/05/2024 | 20:01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/05/2024 | 20:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/05/2024 | 20:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/17/2023 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 12/15/2023 | 16:00 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 12/07/2023 | 15:05 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
| 11/09/2023 | 15:09 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 11/09/2023 | 15:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/10/2023 | 15:18 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/10/2023 | 15:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 8/03/2023 | 15:31 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DRMA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3382 | 0.3583 | 0.321 | 0.3415257 | 23,322 | 0.0045 | 1.33% |
| 1 Month | 0.40 | 0.4444 | 0.237372 | 0.3039369 | 183,416 | -0.0573 | -14.33% |
| 3 Months | 0.462 | 0.508 | 0.237372 | 0.3711188 | 128,124 | -0.1193 | -25.82% |
| 6 Months | 0.6554 | 0.975 | 0.237372 | 0.6191356 | 534,470 | -0.3127 | -47.71% |
| 1 Year | 1.92 | 2.8101 | 0.237372 | 0.9255203 | 376,195 | -1.58 | -82.15% |
| 3 Years | 92.80 | 111.20 | 0.237372 | 10.47 | 784,912 | -92.46 | -99.63% |
| 5 Years | 92.80 | 111.20 | 0.237372 | 10.47 | 784,912 | -92.46 | -99.63% |
Dermata Therapeutics Description
| Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. |
